本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rocket Pharmaceuticals, Inc.

3.78
+0.25007.08%
盤後3.73-0.0500-1.32%17:07 EDT
成交量:220.15萬
成交額:823.80萬
市值:4.15億
市盈率:-22.24
高:3.81
開:3.54
低:3.54
收:3.53
52周最高:5.45
52周最低:2.53
股本:1.10億
流通股本:8,496.03萬
量比:2.00
換手率:2.59%
股息:- -
股息率:- -
每股收益(TTM):-0.1700
每股收益(LYR):-2.0100
淨資產收益率:-4.77%
總資產收益率:-28.42%
市淨率:1.13
市盈率(LYR):-1.88

資料載入中...

2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/07/31

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/30

重要事件披露

Form 8-K - Current report
2026/06/12

重要事件披露

Form 8-K - Current report
2026/05/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/21

重要事件披露

Form 8-K - Current report
2026/05/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities